MLAB — Mesa Laboratories Income Statement
0.000.00%
Last trade - 00:00IndustrialsBalancedMid CapHigh Flyer
- $913.45m
- $1.08bn
- $184.34m
- 95
- 20
- 79
- 72
Annual income statement for Mesa Laboratories, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 96.2 | 103 | 118 | 134 | 184 |
| Cost of Revenue | |||||
| Gross Profit | 54.6 | 60.9 | 64.9 | 87 | 109 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 94 | 93.4 | 110 | 122 | 180 |
| Operating Profit | 2.18 | 9.78 | 7.49 | 12.4 | 4.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.301 | 8.62 | 3.43 | 2.3 | 3.57 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.02 | 7.53 | 1.35 | 3.27 | 1.87 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -2.96 | 7.48 | 1.35 | 3.27 | 1.87 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.96 | 7.48 | 1.35 | 3.27 | 1.87 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.58 | 3.61 | 0.36 | 0.65 | 0.351 |
| Dividends per Share |